Rosetta Genomics Ltd.
ROSG
ROSG was delisted on the 21st of May, 2018.
8 hedge funds and large institutions have $552K invested in Rosetta Genomics Ltd. in 2018 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 2 increasing their positions, 0 reducing their positions, and 3 closing their positions.
97% more capital invested
Capital invested by funds: $280K → $552K (+$272K)
20% less funds holding
Funds holding: 10 → 8 (-2)
67% less first-time investments, than exits
New positions opened: 1 | Existing positions closed: 3
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
SM
Sabby Management
Miami Beach,
Florida
|
+$453K |
| 2 |
Morgan Stanley
New York
|
+$7.13K |
| 3 |
UBS Group
Zurich,
Switzerland
|
+$4.55K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VF
Virtu Financial
New York
|
-$43K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$20K |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
SM
1
Sabby Management
Miami Beach,
Florida
| $383K | +$453K | +934,608 | New |
|
|
2
Morgan Stanley
New York
| $160K | +$7.13K | +14,700 | +4% |
|
|
3
UBS Group
Zurich,
Switzerland
| $6K | +$4.55K | +9,372 | +170% |
|
|
HCM
4
Highlander Capital Management
Short Hills,
New Jersey
| $3K | – | – | – |
|
|
VF
5
Virtu Financial
New York
| – | -$43K | -76,846 | Closed |
|
|
6
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$20K | -36,171 | Closed |
|
ROSG Hedge Fund Activity: Q1 2018 in Review
8 of the 4,363 institutional investors tracked by Wall St. Rank reported a position in Rosetta Genomics Ltd. (ROSG) for Q1 2018, worth a combined $552K — up 97% from $280K a quarter earlier.
Sellers outnumbered buyers: 3 funds closed out of ROSG and 1 opened new positions — a net loss of 2 holders — while 0 trimmed existing stakes and 2 added.
The largest buyer was Sabby Management, opening a new position worth an estimated $453K. The largest seller was Virtu Financial, exiting entirely with an estimated $43K sold.
- 8 institutional investors held Rosetta Genomics Ltd. (ROSG) as of Q1 2018, down from 10 in Q4 2017.
- Funds reported $552K of Rosetta Genomics Ltd. stock for Q1 2018, up 97% quarter-over-quarter.
- 1 fund opened new Rosetta Genomics Ltd. positions in Q1 2018 and 3 closed out, a net change of -2 holders.
- The largest Rosetta Genomics Ltd. buyer in Q1 2018 was Sabby Management, an estimated $453K added.
- The largest Rosetta Genomics Ltd. seller in Q1 2018 was Virtu Financial, an estimated $43K sold.
Based on aggregated 13F filings for Q1 2018.